Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-25 @ 2:16 AM
NCT ID:
NCT02166060
Eligibility Criteria:
Inclusion Criteria:
* heart failure NYHA II-IV
* left ventricular ejection fraction =\<35%
* CRT-D implanted over 3 months ago
* optimal CRT-D parameters
* biventricular pacing \<95% despite the optimal parameters of the device
* optimal pharmacotherapy with the highest well-tolerated beta-adrenolytic dosage
* heart rate at rest below 70 bpm
* over 50% of heart rhythm over 70 bpm at interrogation with the device
Exclusion Criteria:
* persistent atrial fibrillation/flutter
* device associated ineffective resynchronization
* contraindications to ivabradine
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02166060
Study Brief:
Protocol Section:
NCT02166060